CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50.
Chi Y, Xue J, Huang S, Xiu B, Su Y, Wang W, Guo R, Wang L, Li L, Shao Z, Jin W, Wu Z, Wu J.
Chi Y, et al. Among authors: jin w.
Theranostics. 2019 Sep 21;9(23):6840-6855. doi: 10.7150/thno.36338. eCollection 2019.
Theranostics. 2019.
PMID: 31660072
Free PMC article.